US Patent Issued to Imperial College Innovations on July 28 for "Treatment of pulmonary arterial hypertension" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,121, issued on July 28, was assigned to Imperial College Innovations Ltd. (London).

"Treatment of pulmonary arterial hypertension" was invented by Lan Zhao (South Kensington, Great Britain), David Owen (South Kensington, Great Britain) and Martin Wilkins (South Kensington, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention generally relates to products for use in the treatment and/or prevention of Pulmonary Arterial Hypertension (PAH). More specifically, the invention relates to translocator protein (TSPO) binding members which treat or prevent pulmonary endothelial cell dysfunction, and the use of such TSPO binding members f...